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As one of the possible technologies to improve the oral ab-
sorption of poorly water-soluble drugs, supersaturable
formulation, which enables to dissolve the drug to the higher
concentration than their equilibrium solubility, is now attract-
ing the attention [1]. This include salt-formation, solid-
dispersion, co-crystallization or the use of amorphous form.
Since supersaturation is a thermodynamically metastable state,
supersaturated solution has a high potential to precipitate. Some
pharmaceutical excipients, such as hydroxypropyl methylcel-
lulose (HPMC), are used as precipitation inhibitors to stabilize
the supersaturated state of drugs in the GI tract [2]. In addi-
tion, re-dissolution process of the precipitated drug might play
an important role to improve the oral absorption even though
there is little evidence to support it. In this study, for better
understanding the in vivo performance of supersaturable for-
mulations, precipitation/re-dissolution processes of BCS class
2 drug from a supersaturated solution were investigated in the
presence or absence of HPMC.The contribution of re-dissolution
process on the total drug absorption was also evaluated.
Danazol was used as a model drug of BCS class 2 and its
supersaturated solution was prepared by solvent shift method
[3]. Briefly, danazol was completely dissolved in DMSO as a stock
solution, then the stock solution was diluted with fasted state
simulated intestinal fluid (FaSSIF, pH = 6.5) to obtain a super-
saturated solution.As a control, danazol was directly dispersed
in FaSSIF. Dissolved concentration of the drug was observed
in vitro during 4 h, reflecting a transit time in human GI tract.
As an in vitro index of the dissolved amount of drug, area under
the dissolved concentration–time curve (AUCdissolved) was cal-
culated. Further, the precipitation from the supersaturated
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solution was collected to analyze the particle size. In vivo drug
absorption was evaluated by intra-intestinal administration ex-
periment in rat. Under the anesthesia, a supersaturated solution
was injected into the small intestine, then plasma drug
concentration–time profile was observed.
Dissolved concentration of danazol in the supersaturated
solution was about 15% at 1 min after the dilution regardless
of the presence/absence of HPMC. Supersaturation disap-
peared within 30 min in the absence of HPMC, while the
addition of HPMC greatly stabilized the supersaturated state,
keeping the higher dissolved concentration than that in the
control for 4 hours (Fig. 1). The ratio of AUCdissolved to that in
the control was 1.7-fold in the absence of HPMC and 11-fold
in the presence. However, in the in vivo experiment, addition
of HPMC failed to improve the oral absorption of danazol and
no significant differences were observed in their plasma con-
centrations. Since danazol is a highly permeable drug, it was
considered that the initial dissolved fraction in the supersatu-
rated solution was absorbed quickly from the upper intestine
in vivo, then the effect of prolonged supersaturation by HPMC
was not observed. Interestingly, the fraction of absorbed from
the supersaturated solution was estimated to be 60%, whereas
the initial dissolved fraction was only 15% regardless of the
presence/absence of HPMC. Since it was found that the par-
ticle size of precipitated danazol was much smaller than the
original material, it was suggested that the increase in the re-
dissolution rate from the precipitate contributed to the improved
absorption of danazol. This study indicated the importance of
the re-dissolution process after precipitation from the super-
saturated solution for improving the oral absorption of poorly
soluble drugs.
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Fig. 1 – In vitro dissolved concentration-time profile of
danazol in FaSSIF.
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